Michael F Salvatore

Prof. Michael F Salvatore

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2016 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
Michael F SalvatoreMichael F Salvatore
Michael F Salvatore
ECErin S. Calipari
Erin S. Calipari
SJSara R Jones
Sara R Jones

20 June 2017 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
TCTanya Chotibut
Tanya Chotibut
SMSamantha Meadows
Samantha Meadows
EKElla A. Kasanga
Ella A. Kasanga
TMTamara McInnis
Tamara McInnis
MCMark A. Cantu
Mark A. Cantu
Michael F SalvatoreMichael F Salvatore
Michael F Salvatore


Verified
Journal Article
Open access
PDF file
Michael F SalvatoreMichael F Salvatore
Michael F Salvatore
The mechanistic influences of dopamine (DA) signaling and impact on motor function are nearly always interpreted from changes in nigrostriatal neuron terminals in striatum. This is a standard practice in studies of human Parkinson’s disease (PD) and aging and related animal models of PD and aging-related parkinsonism. However, despite dozens of studies indicating an ambiguous relationship between changes in striatal DA signaling and motor phenotype, this perseverating focus on striatum continues. Although DA release in substantia nigra (SN) was first reported almost 50 years ago, assessment of nigral DA signaling changes in relation to motor function is rarely considered. Whereas DA signaling has been well-characterized in striatum at all five steps of neurotransmission (biosynthesis and turnover, storage, release, reuptake, and post-synaptic binding) in the nigrostriatal pathway, the depth of such interrogations in the SN, outside of cell counts, is sparse. However, there is sufficient evidence that these steps in DA neurotransmission in the SN are operational and regulated autonomously from striatum and are present in human PD and aging and related animal models. To complete our understanding of how nigrostriatal DA signaling affects motor function, it is past time to include interrogation of nigral DA signaling. This brief review highlights evidence that changes in nigral DA signaling at each step in DA neurotransmission are autonomous from those in striatum and changes in the SN alone can influence locomotor function. Accordingly, for full characterization of how nigrostriatal DA signaling affects locomotor activity, interrogation of DA signaling in SN is essential.

28 July 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
Michael F SalvatoreMichael F Salvatore
Michael F Salvatore
TMTamara R. McInnis
Tamara R. McInnis
MCMark A. Cantu
Mark A. Cantu
DADeana M. Apple
Deana M. Apple
BPBrandon Scott PRUETT
Brandon Scott PRUETT

20 June 2017 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
Michael F SalvatoreMichael F Salvatore
Michael F Salvatore
JTJennifer Terrebonne
Jennifer Terrebonne
MCMark A Cantu
Mark A Cantu
TMTamara R McInnis
Tamara R McInnis
KVKaty Venable
Katy Venable
DIDonald K Ingram
Donald K Ingram
The escalating increase in retirees living beyond their eighth decade brings increased prevalence of aging-related impairments, including locomotor impairment (Parkinsonism) that may affect ~50% of those reaching age 80, but has no confirmed neurobiological mechanism. Lifestyle strategies that attenuate motor decline, and its allied mechanisms, must be identified. Aging studies report little to moderate loss of striatal dopamine (DA) or tyrosine hydroxylase (TH) in nigrostriatal terminals, in contrast to ~70%–80% loss associated with bradykinesia onset in Parkinson’s disease. These studies evaluated the effect of ~6 months 30% calorie restriction (CR) on nigrostriatal DA regulation and aging-related locomotor decline initiated at 12 months of age in Brown-Norway Fischer F1 hybrid rats. The aging-related decline in locomotor activity was prevented by CR. However, striatal DA or TH expression was decreased in the CR group, but increased in substantia nigra versus the ad libitum group or 12-month-old cohort. In a 4- to 6-month-old cohort, pharmacological TH inhibition reduced striatal DA ~30%, comparable with decreases reported in aged rats and the CR group, without affecting locomotor activity. The dissociation of moderate striatal DA reduction from locomotor activity seen in both studies suggests that aging-related decreases in striatal DA are dissociated from locomotor decline.